Eric Mosbrooker

Insider Reports History

Location
C/O Horizon Pharma, Plc, Adelaide Chambers, Peter Street, Dublin 8, Ireland
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Mosbrooker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Chief Commercial Officer Common Stock 55K $2.5M $45.38 Oct 3, 2025 Direct
Avidity Biosciences, Inc. Chief Commercial Officer Stock Option (Right to Buy) 177K Oct 3, 2025 Direct

Insider Reports Filed by Eric Mosbrooker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNA Avidity Biosciences, Inc. Oct 3, 2025 3 -$238K 4 Oct 7, 2025 Chief Commercial Officer
RNA Avidity Biosciences, Inc. Sep 3, 2025 3 -$250K 4 Sep 5, 2025 Chief Commercial Officer
RNA Avidity Biosciences, Inc. Aug 6, 2025 4 -$4.64M 4 Aug 8, 2025 Chief Commercial Officer
RNA Avidity Biosciences, Inc. Jan 6, 2025 2 $0 4 Jan 8, 2025 Chief Commercial Officer
RNA Avidity Biosciences, Inc. Jan 6, 2025 0 $0 3 Jan 8, 2025 Chief Commercial Officer
RNA Avidity Biosciences, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
RNA Avidity Biosciences, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
RNA Avidity Biosciences, Inc. Aug 25, 2021 1 $0 4 Aug 27, 2021 Director
RNA Avidity Biosciences, Inc. Aug 25, 2021 0 $0 3 Aug 27, 2021 Director